Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults

[1]  X. Shu,et al.  Cohort Profile: The Shanghai Men's Health Study. , 2015, International journal of epidemiology.

[2]  Sophie V. Eastwood,et al.  Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study , 2015, Diabetologia.

[3]  Martin E. Fernandez-Zapico,et al.  Faculty Opinions recommendation of Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. , 2015 .

[4]  Xu Lin,et al.  Causes of type 2 diabetes in China. , 2014, The lancet. Diabetes & endocrinology.

[5]  Guang Ning,et al.  Diabetes in China: a societal solution for a personal challenge. , 2014, The lancet. Diabetes & endocrinology.

[6]  C. Lynch,et al.  Branched-chain amino acids in metabolic signalling and insulin resistance , 2014, Nature Reviews Endocrinology.

[7]  A. Raghavan,et al.  Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus , 2014, PloS one.

[8]  K. Suhre.  Metabolic profiling in diabetes. , 2014, The Journal of endocrinology.

[9]  A. Lang,et al.  Pharmacological treatment of Parkinson disease: a review. , 2014, JAMA.

[10]  Thomas Kocher,et al.  1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. , 2014, The Journal of clinical endocrinology and metabolism.

[11]  Wei Zheng,et al.  Human metabolic correlates of body mass index , 2013, Metabolomics.

[12]  Christian Gieger,et al.  Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.

[13]  K. Wada,et al.  Branched-chain amino acid intake and the risk of diabetes in a Japanese community: the Takayama study. , 2013, American journal of epidemiology.

[14]  Jiang He,et al.  Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.

[15]  T. Foltynie,et al.  Exenatide and the treatment of patients with Parkinson's disease. , 2013, The Journal of clinical investigation.

[16]  Atul J. Butte,et al.  Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response , 2013, Diabetes Care.

[17]  Choon Nam Ong,et al.  Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. , 2013, The Journal of clinical endocrinology and metabolism.

[18]  Gabi Kastenmüller,et al.  Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance , 2013, Diabetes.

[19]  J. Chan,et al.  Annals of the New York Academy of Sciences Type 2 Diabetes in East Asians: Similarities and Differences with Populations in Europe and the United States , 2022 .

[20]  Wei Zheng,et al.  Metabolomics in Epidemiology: Sources of Variability in Metabolite Measurements and Implications , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[21]  Wei Jia,et al.  Metabolomics in human type 2 diabetes research , 2013, Frontiers of Medicine.

[22]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[23]  J. Krieger,et al.  BDKRB2 +9/−9 Polymorphism Is Associated with Higher Risk for Diabetes Mellitus in the Brazilian General Population , 2012, Experimental diabetes research.

[24]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[25]  Olle Korsgren,et al.  A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. , 2012, Cell metabolism.

[26]  F. Hu,et al.  Erythrocyte n-3 fatty acids and metabolic syndrome in middle-aged and older Chinese. , 2012, Journal of Clinical Endocrinology and Metabolism.

[27]  H. Tomita,et al.  The kallikrein-kinin system in diabetic nephropathy , 2012, Kidney international.

[28]  D. Schoepf,et al.  Type-2 diabetes mellitus in schizophrenia: Increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up , 2012, European Psychiatry.

[29]  An Pan,et al.  Rotating Night Shift Work and Risk of Type 2 Diabetes: Two Prospective Cohort Studies in Women , 2011, PLoS medicine.

[30]  Trisha Greenhalgh,et al.  Risk models and scores for type 2 diabetes: systematic review , 2011, BMJ : British Medical Journal.

[31]  P. Marquez,et al.  Toward a healthy and harmonious life in China : stemming the rising tide of non-communicable diseases , 2011 .

[32]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[33]  R. DeFronzo.  Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes , 2011, Diabetes Care.

[34]  J. Stamler,et al.  Higher branched-chain amino acid intake is associated with a lower prevalence of being overweight or obese in middle-aged East Asian and Western adults. , 2011, The Journal of nutrition.

[35]  M. Schulze,et al.  Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2011, The American journal of clinical nutrition.

[36]  HU FRANKB.,et al.  Globalization of Diabetes , 2011, Diabetes Care.

[37]  O. Franco,et al.  Bidirectional association between depression and type 2 diabetes mellitus in women. , 2010, Archives of internal medicine.

[38]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[39]  S. Sharp,et al.  Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. , 2010, The American journal of clinical nutrition.

[40]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[41]  M. Wahlqvist,et al.  Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China. , 2010, Molecular nutrition & food research.

[42]  E. Tai,et al.  Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men , 2010, Diabetologia.

[43]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[44]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[45]  Bo Zhang,et al.  The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study , 2008, The Lancet.

[46]  T. Miyata,et al.  Relationship between serum concentrations of saturated fatty acids and unsaturated fatty acids and the homeostasis model insulin resistance index in Japanese patients with type 2 diabetes mellitus. , 2007, The journal of medical investigation : JMI.

[47]  D. English,et al.  Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. , 2007, The American journal of clinical nutrition.

[48]  Frances S. Turner,et al.  Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes , 2006, Nucleic acids research.

[49]  N. Rothman,et al.  The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. , 2005, American journal of epidemiology.

[50]  L. Chao,et al.  Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. , 2005, Diabetes.

[51]  E. Antunes,et al.  The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system. , 2005, Current medicinal chemistry. Cardiovascular and hematological agents.

[52]  Robert A. Harris,et al.  Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. , 2004, The Journal of nutrition.

[53]  Graeme Eisenhofer,et al.  Sources and Significance of Plasma Levels of Catechols and Their Metabolites in Humans , 2003, Journal of Pharmacology and Experimental Therapeutics.